Kidney Week

Abstract: INFO06

APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

Session Information

• Informational Posters
  October 25, 2018 | Location: Exhibit Hall, San Diego Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category:

• No subcategory defined

Authors

• Palmer, Nicholette D., Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Nicholette D. Palmer,

• Alexander, Amir, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Amir Alexander,

• Russell, Laurie P., Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Laurie P. Russell,

• Smith, Carrie, Wake Forest Universtiy Health Sciences, Winston Salem, North Carolina, United States

Carrie Smith,

• Kimmel, Paul L., National Institute of Diabetes and Digestive Kidney Diseases (NIDDK), Bethesda, Maryland, United States

Paul L. Kimmel,

• Reboussin, David, Wake Forest University Sch of Med, Winston-Salem, North Carolina, United States

David Reboussin,

• Freedman, Barry I., Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Barry I. Freedman,

Group or Team Name

• APOLLO Investigators

Description

The NIH-sponsored APOLLO study will prospectively assess outcomes after kidney transplantation from donors with recent African ancesty based on their apolipoprotein 1 (APOL1) genotypes. Eligible donors include African Americans, Hispanic blacks, Afro-Caribbeans and Africans. APOLLO will also assess the safety of living kidney donation based on APOL1 genotypes.

Funding

• NIH